MSCs have immunosuppressive properties which are of great interest in the making of medication for the treatment of brain injury. The addition of Mesenchymal cells into an allergenic skin graft delayed the rejection from 7 days to 11 days and therefore an explanation of how this is important in the treatment of brain injuries. MSCs also have regenerative capabilities which are being deployed in the treatment of brain injury. There are therefore many studies reporting the efficiency with which Mesenchymal cells can perform perfectly within the brain and make it free from injuries sustained in different ways.